These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15090101)

  • 1. Avoidance of anticipated regret: the ordering of prostate-specific antigen tests.
    Sorum PC; Mullet E; Shim J; Bonnin-Scaon S; Chasseigne G; Cogneau J
    Med Decis Making; 2004; 24(2):149-59. PubMed ID: 15090101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
    Kuo NW; Lin HC; Lee HC
    J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of PSA in prostate cancer treatment.
    Unger HA; Kane RD; Fox KM; Gandhi S; Alzola C; Lamerato L; Newling D; Kumar S
    Urol Oncol; 2005; 23(4):238-45. PubMed ID: 16018938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are we ordering too many PSA tests? Prostate cancer diagnosis and PSA screening patterns for a single Veterans Affairs Medical Center.
    Richter F; Dudley AW; Irwin RJ; Sadeghi-Nejad H
    J Cancer Educ; 2001; 16(1):38-41. PubMed ID: 11270898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are doctors examining prostates in university hospital?
    Lim CH; Quinlan DM
    Urology; 2007 Nov; 70(5):843-5. PubMed ID: 18068436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients?
    Sorum PC; Shim J; Chasseigne G; Bonnin-Scaon S; Cogneau J; Mullet E
    Med Decis Making; 2003; 23(4):301-13. PubMed ID: 12926580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
    Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
    Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen testing in men older than 75 years in the United States.
    Scales CD; Curtis LH; Norris RD; Schulman KA; Albala DM; Moul JW
    J Urol; 2006 Aug; 176(2):511-4. PubMed ID: 16813879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
    Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB
    Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in prostate specific antigen (PSA) test ordering in primary care centers: tendencies 2002-2009.
    Lumbreras B; López-Garrigos M; Salinas M
    Clin Lab; 2012; 58(5-6):573-7. PubMed ID: 22783591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.
    Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW
    BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prostate-specific antigen testing from 1995 through 2004.
    Farwell WR; Linder JA; Jha AK
    Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.